Open Access537STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96
Author(s) -
Catherine Creticos,
Cynthia Brinson,
Cheryl McDonald,
Sorana SegalMaurer,
Indira Brar,
B Wade,
Will Garner,
Danielle Porter,
Shampa De-Oertel,
Amy R. Weinberg,
Toni Sparrow
Publication year - 2014
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofu051.56
Subject(s) - emtricitabine , rilpivirine , efavirenz , tenofovir , medicine , regimen , pharmacology , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom